Section 639.6703 - Labeling1. Each pharmacist engaged in the practice of compounding nonsterile compounded drug products shall label each nonsterile compounded drug product, including, without limitation, any amount of the nonsterile compounded drug product that is in excess of the amount required by the prescription or chart order and any nonsterile compounded drug product that is compounded in bulk quantities. The label must include, without limitation: (a) The name of the final compounded drug product or the name of each active ingredient present in the nonsterile compounded drug product and, as appropriate, the concentration of each active ingredient in the final compounded drug product;(b) The internal control number assigned to the compounded drug product by the pharmacist; and(c) The beyond-use date of the compounded drug product.2. Each pharmacist engaged in the practice of compounding nonsterile compounded drug products shall ensure that each nonsterile compounded drug product, including, without limitation, any amount of the nonsterile compounded drug product that is in excess of the amount required by the prescription or chart order, and any nonsterile compounded drug product that is compounded in bulk quantities is stored in the pharmacy in a manner that:(a) Maintains the efficacy of the nonsterile compounded drug product; and(b) Ensures that the nonsterile compounded drug product remains free from contamination.Nev. Admin. Code § 639.6703
Added to NAC by Bd. of Pharmacy by R035-06, eff. 9-18-2008; A by R053-24A, eff. 10/23/2024